Organization · Venture Studio
CITES
CITES is a venture studio based in Argentina that co-creates scientific and technological startups. It focuses on transforming disruptive scientific ideas into viable businesses, supporting entrepreneurs from the idea stage through to Series A funding.
Overview
What CITES does
What CITES is
CITES is a venture studio based in Argentina that co-creates scientific and technological startups. It focuses on transforming disruptive scientific ideas into viable businesses, supporting entrepreneurs from the idea stage through to Series A funding.
How it participates in the startup ecosystem
The current public profile supports funder and program host capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Studio
- Structured capabilities
- Funder · Program host
- Last reviewed
- March 5, 2026
What Venture studio means
A venture studio is an organization that systematically creates new startups by generating or sourcing ideas, validating them, building early products, recruiting founders or operators, providing shared resources, and retaining meaningful equity in the companies it helps create.
Open the glossary entryOfficial channels
Find CITES elsewhere
Open the official website or a supported primary organization account.
Capability profile
CITES as a funder
Investment thesis
CITES invests in scientific and technological startups, emphasizing the transformation of disruptive ideas into viable businesses. The organization supports startups from the idea stage through to Series A funding.
Focus narrative
CITES invests in scientific and technological startups across various sectors, including BioTech, HealthTech, AgTech, Smart City & Logistics, FoodTech, MedTech, Robotics, AI, and Pharma and Drug Discovery. The organization provides active management, connections to a global network of mentors and investors, and access to infrastructure such as fab-labs and co-working spaces.
Value beyond capital
CITES provides active management, connections to a global network of mentors and investors, and access to infrastructure such as fab-labs and co-working spaces to support startups.
Terms and economics
- Typical check
- $25,000–$15,000,000
Focus and fit
- Stages
- Pre-seed · Seed · Series A
- Sectors
- Biotech & Life SciencesHealthcareAgTechClimate & SustainabilityFood & AgricultureRobotics & Autonomous SystemsArtificial Intelligence
- Regions
- Latin America
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 23
Portfolio context
CITES has invested in over 23 companies, focusing on innovative solutions in various fields. Notable portfolio companies include a biotech firm developing cardiac regenerative therapies, a company creating smart intra-articular prosthetics for ACL replacement, a firm working on genetic herbicides for sustainable weed control, a startup developing new generation cardiac valve prosthetics, a company focused on innovative therapies for obesity and Type II diabetes, and a lab service aimed at accelerating drug discovery.
Capability profile
CITES as a program host
Program thesis
CITES aims to drive societal progress by investing in and nurturing scientific and technological innovations. The organization emphasizes the importance of knowledge and talent in building successful startups.
Focus narrative
CITES invests in a diverse range of sectors, including BioTech, HealthTech, AgTech, Smart City & Logistics, FoodTech, MedTech, Robotics, AI, and Pharma. The organization is committed to fostering innovative solutions that address pressing societal challenges and enhance quality of life.
Value and support
Founders benefit from CITES' extensive support, including active management, mentorship, access to a global network of investors, and infrastructure resources. This comprehensive approach helps startups navigate their growth journey effectively.
Terms and economics
- Indicative investment
- $25,000
Availability
- Application state
- Accepting
Focus and fit
- Stages
- Pre-seed · Seed · Seed+ · Series A
- Sectors
- Biotech & Life SciencesHealthcareAgTechLogistics & Supply ChainFood & AgricultureRobotics & Autonomous SystemsArtificial Intelligence
- Regions
- Latin America
Alumni and track record
Alumni context
CITES has invested in over 23 companies, including a biotech firm developing cardiac regenerative therapies and a company creating smart intra-articular prosthetics for ACL replacement. Other notable alumni include firms working on genetic herbicides for sustainable weed control and innovative therapies for obesity and Type II diabetes.
Common questions
What to know about CITES
Upseed classifies CITES under the Venture Studio organization type. Its current public profile includes funder and program host capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 5, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.